Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$5.37 - $8.38 $5,370 - $8,380
-1,000 Reduced 22.22%
3,500 $5,000
Q3 2021

Oct 26, 2021

SELL
$7.36 - $13.67 $52,992 - $98,424
-7,200 Reduced 61.54%
4,500 $7,000
Q2 2021

Jul 19, 2021

BUY
$8.42 - $13.96 $1,684 - $2,792
200 Added 1.74%
11,700 $8,000
Q1 2021

Apr 26, 2021

SELL
$3.2 - $16.51 $165,440 - $853,567
-51,700 Reduced 81.8%
11,500 $2,000
Q4 2020

Jan 21, 2021

BUY
$2.92 - $4.84 $150,380 - $249,260
51,500 Added 440.17%
63,200 $46,000
Q3 2020

Oct 27, 2020

BUY
$3.03 - $5.48 $34,845 - $63,020
11,500 Added 5750.0%
11,700 $23,000
Q1 2020

May 07, 2020

SELL
$3.53 - $12.21 $18,709 - $64,713
-5,300 Reduced 96.36%
200 $3,000
Q4 2019

Feb 06, 2020

BUY
$11.58 - $17.37 $31,266 - $46,899
2,700 Added 96.43%
5,500 $15,000
Q3 2019

Oct 28, 2019

SELL
$13.91 - $19.87 $20,865 - $29,805
-1,500 Reduced 34.88%
2,800 $7,000
Q2 2019

Aug 09, 2019

BUY
$13.19 - $28.36 $9,233 - $19,852
700 Added 19.44%
4,300 $26,000
Q1 2019

May 10, 2019

BUY
$12.43 - $28.91 $32,318 - $75,166
2,600 Added 260.0%
3,600 $3,000
Q4 2018

Feb 05, 2019

BUY
$10.57 - $19.29 $10,570 - $19,290
1,000 New
1,000 $1,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $708M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.